Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Immunogenetic predictors of a rapid virologic response to antiviral therapy in patients with chronic hepatitis C].

Terapevticheskii arkhiv - 1 Jan 2012

Yushchuk N D, Znoiko O O, Balmasova I P, Fedoseyeva N V, Shmeleva E V, Dudina K R, Klimova E A, Petrova T V, Trofimov D Yu, Belyi P A, Safiullina N Kh, Pypkina E V

Abstract excerpt

AIM: To determine the correlation between interleukin 28B (IL28B) gene polymorphism in patients with chronic hepatitis C (CHC), the presence or absence a rapid virologic response to antiviral therapy, and a number of immunological characteristics as a basis for a personalized approach to treating the patients. SUBJECTS AND METHODS: Seventeen CHC patients infected with hepatitis C virus genotype 1b were examined...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Flow Cytometry

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis C, Chronic

Share to Immunogenetic Phenomena

Share to Interferons

Share to Interleukins

Share to Killer Cells, Natural

Share to T-Lymphocytes, Regulatory

Source

Identifiers

PMID: 23252241

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Immunogenetic predictors of a rapid virologic response to antiviral therapy in patients with chronic hepatitis C].PMID 23252241Read ↗

[Association of interleukin 28B polymorphisms with response to pegylatedinterferon plus ribavirin therapy for chronic hepatitis C].Semantic proximity Read ↗

[IL28B CC genotype: a protective factor and predictor of the response to interferon treatment in chronic hepatitis C virus infection].Semantic proximity Read ↗

[Genetic polymorphisms as new predictive factors for successful treatment of chronic hepatitis C].Semantic proximity Read ↗

IL28B rs12980275 and HLA rs4273729 genotypes as a powerful predictor factor for rapid, early, and sustained virologic response in patients with chronic hepatitis C.Semantic proximity Read ↗

[Evaluation of the antiviral therapy for chronic hepatitis C in patients unresponsive to previous treatment with regard to the interleukin-28B genotypes].Semantic proximity Read ↗

[Genetic polymorphisms of IL-28B are associated with sustained virologic response in patients with chronic hepatitis C].Semantic proximity Read ↗

Baseline factors associated with treatment response in patients infected with hepatitis C virus 1b by stratification of IL28B polymorphisms.Semantic proximity Read ↗

Both Hepatitis C Virus-Specific T Cell Responses and IL28B rs12979860 Single-Nucleotide Polymorphism Genotype Influence Antihepatitis C Virus Treatment Outcome in Patients with Chronic Hepatitis C.Semantic proximity Read ↗

Interferon-λ-related genes and therapeutic response in Chinese hepatitis C patients.Semantic proximity Read ↗

A predictive model of treatment outcome in patients with chronic HCV infection using IL28B and PD-1 genotyping.Semantic proximity Read ↗

[Significance of allelic variants of interleukin-28B gene in chronic hepatitis C].Semantic proximity Read ↗

[Genetic polymorphisms as predictors of response to antiviral treatment in chronic hepatitis C virus infection].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.